Organ-on-a-Chip
Event details
| Date | 27.01.2017 |
| Hour | 15:00 |
| Speaker | Dr. Anthony Bahinski, Wyss Institute for Biologically Inspired Engineering, Boston, MA (USA) |
| Location | |
| Category | Conferences - Seminars |
BIOENGINEERING SEMINAR
Bio:
Dr. Anthony Bahinski research interests are in the development of organ-on-a-chip technology for efficacy and safety evaluation of drugs, biologics, and nanotherapeutics. He received his BS in Biology from Drexel University, PhD in Physiology from Temple University, and MBA from Xavier University. He completed post-doctoral at Rockefeller University and the University of Cincinnati, and is a Fellow of the American Heart Association.
He has led several drug discovery groups and was St. Louis Site Lead of Safety Pharmacology at Pfizer, prior to joining the Wyss Institute.
Dr. Bahinski is on the editorial board of the journals Applied In vitro Toxicology and Frontiers in Pharmacology of Ion Channels and Channelopathies. In addition, he is a member of several external boards including the Science Board of the US FDA.
Bio:
Dr. Anthony Bahinski research interests are in the development of organ-on-a-chip technology for efficacy and safety evaluation of drugs, biologics, and nanotherapeutics. He received his BS in Biology from Drexel University, PhD in Physiology from Temple University, and MBA from Xavier University. He completed post-doctoral at Rockefeller University and the University of Cincinnati, and is a Fellow of the American Heart Association.
He has led several drug discovery groups and was St. Louis Site Lead of Safety Pharmacology at Pfizer, prior to joining the Wyss Institute.
Dr. Bahinski is on the editorial board of the journals Applied In vitro Toxicology and Frontiers in Pharmacology of Ion Channels and Channelopathies. In addition, he is a member of several external boards including the Science Board of the US FDA.
Links
Practical information
- Informed public
- Free
- This event is internal